Variables | One time hepatic inflow occlusion | Two times hepatic inflow occlusion | p-value |
---|---|---|---|
n = 78 | n = 25 | ||
Gender (%) | Â | Â | 0.077 |
 Male | 74 (94.9) | 21 (84.0) |  |
 Female | 4 (5.1) | 4 (16.0) |  |
Age (y) | 43.9 ± 11.4 | 39.1 ± 11.0 | 0.498 |
Length (%) | Â | Â | 0.061 |
  ≤ 5 cm | 20 (25.6) | 2 (8.0) |  |
  > 5 cm | 58 (74.4) | 23 (92.0) |  |
Tumor number (%) | Â | Â | 0.567 |
 Single | 58 (74.4) | 20 (80.0) |  |
 Multiple | 20 (25.6) | 5 (20.0) |  |
BCLC stage (%) | Â | Â | 0.2 |
 A | 41 (52.6) | 8 (32.0) |  |
 B | 17 (21.8) | 8 (32.0) |  |
 C | 20 (25.6) | 9 (36.0) |  |
Child–Pugh (%) |  |  | 0.654 |
 A | 59 (75.6) | 20 (80.0) |  |
 B | 19 (24.4) | 5 (20.0) |  |
AFP (%) | Â | Â | 0.093 |
  ≤ 400 ng/ml | 31 (39.7) | 5 (20.0) |  |
  > 400 ng/ml | 47 (60.3) | 21 (84.0) |  |
Edmondson-steiner (%) | Â | Â | 0.115 |
 I | 7 (9.0) | 1 (4.0) |  |
 II | 45 (57.7) | 9 (36.0) |  |
 III | 14 (17.9) | 7 (28.0) |  |
 IV | 12 (15.4) | 8 (32.0) |  |
Necrosis (%) | Â | Â | 0.136 |
 No | 64 (82.1) | 17 (68.0) |  |
 Yes | 14 (17.9) | 8 (32.0) |  |
Local invasion (%) | Â | Â | 0.188 |
 No | 43 (55.1) | 10 (40.0) |  |
 Yes | 35 (44.9) | 15 (60.0) |  |
ALB (g/L) | 35.6 (31.3–38.1) | 36.5 (34.3–43.5) | 0.053 |
ALT (U/L) | 27.0 (20.5–41.8) | 30.0 (24.0–49.0) | 0.636 |
AST (U/L) | 35.0 (22.0–65.3) | 50.0 (31.5–80.0) | 0.017 |
ALP (U/L) | 77.0 (61.0–91.3) | 72.0 (61.5–98.0) | 0.661 |
GGT (U/L) | 55.5 (36.0–122.3) | 58.0 (29.5–147.5) | 0.929 |
HBsAg (%) | Â | Â | 0.881 |
 No | 7 (9.0) | 2 (8.0) |  |
 Yes | 71 (91.0) | 23 (92.0) |  |